Jersey Shore Ready ...
Health Care: Health Services
GenMark Diagnostics Inc. (GNMK: NASDAQ)
$14.77 0.11 | 0.75%
05/24/13 - 04:00 PM ET
Company Cash Flow
| Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
| Cash Flow From Operating Activities | ||||
|---|---|---|---|---|
| Net Income (Loss) | -22.10M | -23.97M | -18.40M | -19.96M |
| Operating Gains/Losses | 0.00 | 0.00 | 0.00 | 8.46K |
| Extraordinary Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 |
| (Increase) Decrease In Receivables | -2.07M | -420.00K | -507.81K | -51.07K |
| (Increase) Decrease in Inventories | -880.00K | -1.74M | -651.13K | 1.23M |
| (Increase) Decrease In Other Current Assets | 68.00K | 0.00 | -1.40M | 315.98K |
| (Decrease) Increase In Payables | 728.00K | 378.00K | -1.06M | -857.31K |
| (Decrease) Increase In Other Current Liabilities | 1.81M | 979.00K | 547.67K | -510.17K |
| (Increase) Decrease In Other Working Capital | 1.40M | 1.85M | 0.00 | 0.00 |
| Other Non-Cash Items | 3.61M | 2.39M | 1.55M | 2.82M |
| Net Cash From Continuing Operations | -16.24M | -19.21M | -18.86M | -15.44M |
| Net Cash From Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Provided By Investing Activities | ||||
| Net Cash From Total Operating Activities | -16.24M | -19.21M | -18.86M | -15.44M |
| Sale of Property, Plant & Equipment | 0.00 | 0.00 | 0.00 | 10.00K |
| Cash Used for Investing Activities | ||||
| Sale of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Property, Plant & Equipment | -4.80M | -2.11M | -1.86M | -1.07M |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 |
| Purchases of Short-Term Investments | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Cash from Investing Activities | 3.66M | 0.00 | 0.00 | 0.00 |
| Cash Provided by Financing Activities | ||||
| Net Cash From Investing Activities | -2.15M | -7.11M | -1.86M | -1.06M |
| Issuance of Debt | 991.00K | 2.00M | 0.00 | 0.00 |
| Cash Used for Financing Activities | ||||
| Issuance of Capital Stock | 48.52M | 34.53M | 27.60M | 24.13M |
| Repayment of Long-Term Debt | 0.00 | -417.00K | 0.00 | 0.00 |
| Repurchase of Capital Stock | 0.00 | -2.85M | 0.00 | 0.00 |
| Payment of Cash Dividends | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Financing Charges, Net | -5.20M | 0.00 | -4.99M | 0.00 |
| Net Cash From Financing Activities | 44.32M | 33.26M | 22.61M | 24.13M |
| Effect of Exchange Rate Changes | 0.00 | 53.00K | -46.94K | 29.80K |
| Net Change in Cash & Cash Equivalents | 25.93M | 6.99M | 1.85M | 7.66M |
Portfolios with GNMK
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorBarron's Insider Purchases ...
Latest GNMK Headlines from TheStreet
- 4 Stocks Under $5 Making Big Up Moves 07.10.12 | 02:07 pm
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 06.29.12 | 05:06 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 11.23.11 | 06:11 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.26.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Downgraded (GNMK) 08.11.11 | 07:08 am
- GenMark Diagnostics Inc. Stock Upgraded (GNMK) 08.09.11 | 07:08 am
- GenMark Diagnostics To Present At The Piper Jaffray 22nd Annual Health Care Conference 11.24.10 | 09:11 am
- GenMark Diagnostics To Present At William Blair Emerging Growth Stock Conference 10.01.10 | 07:10 am
- GenMark IPO Better than Mirion IPO
05.25.10 | 06:05 am
Press Releases for GNMK
- GenMark Diagnostics Reports Fourth Quarter And Year End 2012 Results - Business Wire 03.12.13 | 04:03 pm
- GenMark Diagnostics Schedules Fourth Quarter And Full Year 2012 Financial Results And Conference Call For March 12, 2013 - Business Wire 02.28.13 | 05:02 pm
- GenMark Diagnostics To Present At The 31st Annual J.P. Morgan Healthcare Conference - Business Wire 01.04.13 | 04:01 pm
- GenMark Diagnostics To Present At The Canaccord Genuity Medical Technology & Diagnostics Forum - Business Wire 11.26.12 | 09:11 am
- GenMark Diagnostics To Present At The Piper Jaffray 24th Annual Healthcare Conference - Business Wire 11.20.12 | 06:11 pm
- GenMark Diagnostics Reports Third Quarter 2012 Results - Business Wire 11.07.12 | 06:11 pm
- GenMark Diagnostics Schedules Third Quarter 2012 Financial Results And Conference Call For November 8, 2012 - Business Wire 10.26.12 | 02:10 pm
- GenMark To Show Its All-Electronic, Sample-to-Answer Molecular Diagnostics Platform At The Association For Molecular Pathology Meeting - Business Wire 10.22.12 | 09:10 am
- GenMark Diagnostics Receives FDA Clearance For RVP Test - Business Wire 09.12.12 | 09:09 am
- GenMark Diagnostics To Present At Canaccord Genuity 32nd Annual Growth Conference - Business Wire 08.15.12 | 09:08 am
Partner Headlines for GNMK
- FDA Clears GenMark's Newest Test - Analyst Blog - NASDAQ 09.13.12 | 04:09 pm
- Weekly CFO Buys Highlight: XPL, GNMK - GuruFocus 07.02.12 | 12:07 pm
- Weekly CEO Buys Highlight: SXL, JBSS, GNMK, CNDO, DCO - GuruFocus 06.30.12 | 02:06 pm
- GenMark Diagnostics Appoints Richard B. Slansky Chief Financial Officer - Benzinga 04.02.12 | 04:04 pm
- After Shaky August, IPO Market Attempts To Right Itself - Seeking Alpha 09.23.11 | 08:09 am
- 10 Rallying Small-Caps Bought Up By Insiders - Seeking Alpha 09.16.11 | 04:09 pm
- 2010 Year-End U.S. IPO Review and 2011 Outlook - Seeking Alpha 03.04.11 | 02:03 pm
- William Blair & Co. Initiates Outperform Rating on GenMark Diagnostics (GNMK) - Benzinga 07.12.10 | 09:07 am
